Cytokinetics, IncorporatedCYTKNASDAQ
Loading
SG&A Expense Growth TrendStable
Percentile Rank71
3Y CAGR-27.4%
5Y CAGR-0.8%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-27.4%/yr
Annual compound
5Y CAGR
-0.8%/yr
Recent deceleration
Percentile
P71
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive growthStable
| Period | Value |
|---|---|
| 2025 | 32.03% |
| 2024 | 24.02% |
| 2023 | -2.45% |
| 2022 | 83.85% |
| 2021 | 83.27% |
| 2020 | 33.35% |
| 2019 | 26.62% |
| 2018 | -14.22% |
| 2017 | 31.07% |
| 2016 | 41.47% |